Furthermore, genetic factors may also be implicated.6,7 In SSA, the concept of clinically relevant Hb cut-off points has been applied in some settings, leading to the use of more stringent cut-offs when reporting anaemia in HF in SSA compared to studies from high-income countries.2,8. This evidence concerns the gene GSTM1 and hydrops fetalis.